1. Home
  2. Our Services
  3. Securities
  4. Recent Transactions

 

Announcement Type Status Transaction Value
Aug 2019 Advisory Closed Exclusive Financial advisor to Altas Partners in connection with its acquisition of DuBois Chemicals Undisclosed
Aug 2019 Financing Closed Lead manager to Deciphera Pharmaceuticals on its follow-on offering $460 million
Jul 2019 Advisory Pending Financial advisor to Pfizer in connection with its separation of Up John and combination with Mylan Combined enterprise value of ~$47 billion
Jul 2019 Financing Closed Joint bookrunner to Mirum on its initial public offering $75 million
Jul 2019 Financing Closed Sole bookrunner to Exicure on its confidentially marketed public offering $63 million
Jul 2019 Financing Closed Joint bookrunner to Ra Pharmaceuticals on its follow-on offering $149.5 million
Jul 2019 Financing Closed Lead manager to Avrobio on its confidentially marketed public offering $138 million
Jul 2019 Financing Closed Lead manager to Forty Seven on its confidentially marketed public offering $86 million
Jul 2019 Financing Closed Co-manager to Seattle Genetics, Inc. on its confidentially marketed public offering $575 million
Jul 2019 Advisory Closed Financial advisor to Engie in connection with its acquisition of Conti and its affiliated companies Undisclosed


© 2019 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.